A packed schedule of 41 educational sessions and 12 methods workshops are available Saturday for attendees who have added the Educational Program Pass to their Annual Meeting registrations.

Representatives from the U.S. Food and Drug Administration will join with leaders from academia, industry, and the patient advocacy community to discuss the impact of regulatory science on the evaluation of new cancer medicines.

A series of three sessions will provide an exciting, behind-the-scenes glimpse at the inventive and state-of-the-art strategies in drug design and development in oncology.

A track of sessions will allow Annual Meeting attendees to review recent progress in the understanding and treatment of blood cancers such as leukemia, lymphoma, and multiple myeloma.

More than 22,000 attendees and a record number of submitted abstracts reflect the cancer research community’s commitment to inspiring science, fueling progress, and revolutionizing care during the AACR Annual Meeting 2024.

Annual Meeting Program Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, preview notable items on Friday’s schedule to help you plan your day.

Eleven educational sessions and four methods workshops are available Friday for attendees who have added the Educational Program Pass to their Annual Meeting registrations.

Programming throughout the Annual Meeting will help attendees gain a deeper understanding of computational methods that are redefining the scope, speed, and precision of cancer research.

An interdisciplinary team of academics and healthcare professionals will be recognized for their work that has led to fundamental changes in endometrial cancer prevention strategies and clinical practice guidelines.

A special “Advances In…” track of sessions during the Annual Meeting will focus on innovative tools that are setting the stage for breakthroughs in all areas of cancer research.